公司概覽
業務類別 Medical Devices
業務概覽 Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
公司地址 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
電話號碼 +1 508 683-4000
傳真號碼 +1 508 650-8923
公司網頁 https://www.bostonscientific.com
員工數量 59000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Miriam O’Sullivan Senior Vice President and Chief Human Resources Officer -- 19/03/2025
Mr. Vance R. Brown Senior Vice President, General Counsel, Corporate Secretary -- 19/03/2025
Mr. Jonathan R. Monson Executive Vice President and Chief Financial Officer -- 17/02/2026
Mr. Joseph M. Fitzgerald Executive Vice President and Group President, Cardiology 美元 842.36K 19/03/2025
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 美元 1.40M 17/02/2026
Mr. John Bradley Sorenson Executive Vice President, Global Operations -- 19/03/2025
Mr. Arthur C. Butcher Executive Vice President and Group President, MedSurg and Asia Pacific 美元 708.88K 19/03/2025
Ms. Emily M. Woodworth Senior Vice President, Global Controller and Chief Accounting Officer -- 17/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Edward J. Ludwig Lead Independent Director 17/02/2026
Mr. David S. Wichmann Independent Director 17/02/2026
Ms. Ellen M. Zane Independent Director 17/02/2026
Mr. Yoshiaki Fujimori Independent Director 05/02/2026
Senator John E. Sununu Independent Director 17/02/2026
Ms. Susan E. Morano Independent Director 17/02/2026
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 17/02/2026
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director 17/02/2026
Mr. David C. Habiger Independent Director 17/02/2026
Mr. Christophe Pierre Weber Director 23/02/2026
Ms. Catherine R. Smith Director 23/02/2026
Dr. Cheryl B. Pegus, M.D. Independent Director 17/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:33)
代號 名稱 佔比% 持有日期
DSPYTema S&P 500 Hist Wght ETF Strat0.002%27/02/2026
VOTETCW Transform 500 ETF0.002%27/02/2026
NMAINuveen Multi-Asset Income0.002%31/12/2025
GUSEGoldman Sachs Enhanced U.S. Equity ETF0.002%27/02/2026
CSMProShares Large Cap Core Plus0.002%27/02/2026
SPXXNuveen S&P 500 Dynamic Overwrite0.002%31/12/2025
JCENuveen Core Equity Alpha0.002%31/12/2025
HAPIHarbor Human Capital Factor US LrgCapETF0.002%28/02/2026
AGNGGlobal X Aging Population ETF0.001%27/02/2026
KOMPStt Strt®SPDR®S&PKenshoNwEcosComposETF0.001%27/02/2026
CVLCCalvert US Large-Cp Cor Rspnb ETF0.001%27/02/2026
KWINKraneShares Wahed Alternative Inc IdxETF0.001%27/02/2026
PCLGPolen Focus Growth ETF0.001%31/12/2025
JHMLJHancock Multifactor Large Cap ETF0.001%27/02/2026
AAEQAlpha Architect US Equity 2 ETF0.001%22/01/2026
EPSWisdomTree U.S. LargeCap Fund0.001%27/02/2026
ETWEV Tax-Managed Glb B-W Opps0.001%31/12/2025
SFYSoFi Select 500 ETF0.001%27/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.001%27/02/2026
XVViShares ESG Select Screened S&P 500 ETF0.001%28/02/2026
  1    2    3    4    5    6    7   8    9    10    11    12    13    14    15    16    17    18    19  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.